Vincera is expected to have approximately $60 million at closing to fund clinical and preclinical development...
NEW YORK, May 06, 2020 (GLOBE NEWSWIRE) -- LifeSci Acquisition Corp. (NASDAQ: LSAC) (the “Company”) announced...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.